Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filing Details

Document Details

Form
Filing Date
Jun 26, 2017
Document Date
Jun 23, 2017
Form Description

Report of unscheduled material events or corporate event

Filing Group
Current Reports
Company
Agios Pharmaceuticals, Inc. – IR Site
Issuer
AGIOS PHARMACEUTICALS INC